There having the rally I predicted yesterday but does not change my fundamental view that they will go bust like CLH
Looking at the market overall and the monthly ASX charts if we retest the recent lows and they hold there is a chance for the ASX to retest circa 5600.
Thats a near 20% rise from here and as stocks such as CCP and Afterpay have had exaggerated market moves from a trading perspective there is a potential another 50% upside as the sell off has been relentless and short positions have to be closed.
If you look at the published results there cost of collections is rising every year so it's becoming more difficult to collect debt.
in answer to the poster who said to conserve cash they simply need to stop purchasing PDL books, but in that scenario they offer no growth.
Apart from this the newest debts are easiest to collect and the aged debt much more difficult and you would see a significant hit to EBITDA
- Forums
- ASX - By Stock
- CCP
- Ann: COVID-19 - Credit Corp withdraws FY20 guidance
CCP
credit corp group limited
Add to My Watchlist
1.33%
!
$13.71

Ann: COVID-19 - Credit Corp withdraws FY20 guidance, page-57
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.71 |
Change
0.180(1.33%) |
Mkt cap ! $933.1M |
Open | High | Low | Value | Volume |
$13.48 | $13.82 | $13.48 | $3.165M | 230.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 824 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 824 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 824 | 13.700 |
1 | 824 | 13.680 |
1 | 824 | 13.660 |
1 | 824 | 13.640 |
2 | 13 | 13.610 |
Price($) | Vol. | No. |
---|---|---|
13.810 | 824 | 1 |
13.820 | 824 | 1 |
13.840 | 824 | 1 |
13.850 | 1252 | 2 |
13.860 | 824 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CCP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online